Dr. Christopher J. Logothetis MD Medical Oncologist

Dr. Christopher Logothetis is a medical oncologist in Houston, Texas and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from University of Athens and has been in practice for 40 years. Dr. Logothetis accepts several types of health insurance, listed below. He is one of 129 doctors at University of Texas M.D. Anderson Cancer Center who specialize in Medical Oncology.

Are you Dr. Christopher Logothetis? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

University of Texas M.D. Anderson Cancer Center
Ranked #1 in Cancer

Education & Medical Training

University of Texas at Houston
Fellowship, Medical Oncology, 1978 - 1979

University of Texas M D Anderson Cancer Center
Fellowship, Hematology, 1977 - 1978

University of Athens
Class of 1974

Certifications & Licensure

American Board of Family Medicine
Certified in Family Medicine

American Board of Family Medicine
Certified in Sports Medicine

AZ State Medical License
Active through 2014

Publications & Presentations

PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer.
Prensner, J. R.,Chen, W.,Iyer, M. K.,Cao, Q.,Ma, T.,Han, S.,Sahu, A.,Malik, R.,Wilder-Romans, K.,Navone, N.,Logothetis, C. J.,Araujo, J. C.,Pisters, L. L.,Tewari, A. K.,Canman, C. E.,Knudsen, K. E.,Kitabayashi, N.,Rubin, M. A.,Demichelis, F.,Lawrence, T. S.,Chinnaiyan, A. M.,Feng, F. Y.

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial.
Araujo, J. C.,Trudel, G. C.,Saad, F.,Armstrong, A. J.,Yu, E. Y.,Bellmunt, J.,Wilding, G.,McCaffrey, J.,Serrano, S. V.,Matveev, V. B.,Efstathiou, E.,Oudard, S.,Morris, M. J.,Sizer, B.,Goebell, P. J.,Heidenreich, A.,de Bono, J. S.,Begbie, S.,Hong, J. H.,Richardet, E.,Gallardo, E.,Paliwal, P.,Durham, S.,Cheng, S.,Logothetis, C. J.

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial.
Basch, E.,Autio, K.,Ryan, C. J.,Mulders, P.,Shore, N.,Kheoh, T.,Fizazi, K.,Logothetis, C. J.,Rathkopf, D.,Smith, M. R.,Mainwaring, P. N.,Hao, Y.,Griffin, T.,Li, S.,Meyers, M. L.,Molina, A.,Cleeland, C.

See all 101 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Great West PPO
  • Horizon BCBS Direct Access
  • Horizon BCBS HMO
  • Horizon BCBS POS
  • Horizon BCBS PPO
  • Humana ChoiceCare Network PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.